CardioWise, Inc. recently announced that it has partnered with the National Institutes of Health and the National Heart, Lung & Blood Institute to provide its cardiac analysis software for a national clinical research study. The software, Multiparametric Strain Analysis (MPSA), was developed to analyze the three-dimensional motion of the heart acquired from cardiac MRI images. It then compares the analysis to the motion of a normal heart model.
The beta site agreement with the National Institutes of Health and the National Heart, Lung & Blood Institute provides that a study will be performed of the use of bone marrow stem cells during cardiac surgery to treat heart muscle dysfunction associated with ischemic heart disease or damage from heart attack, according to a news release. The study will be conducted at the NIH Heart Center at Suburban Hospital, a member of the Johns Hopkins Medicine system, in Bethesda, Maryland.
For more information about CardioWise, visit the company’s website at http://www.cardiowiseinc.com/.